Biotechnology News This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 21.

Closing in on a Universal Flu Vaccine
Recently, several discoveries have moved us much closer to a universal flu vaccine. For example, one group of researchers successfully completed several years of searching to find antibodies that neutralize the multitude of influenza A and B viruses variants. Also, right around the same time last month, another group showed that individuals who received prior flu vaccinations should still respond strongly to a universal vaccine. Previously, there was concern that a universal flu vaccine would not work with adults that were previous immunized against the flu....Read Full Post
Source: About.com Biotech Biomedical - August 24, 2012 Category: Biotechnology Source Type: news

Disease Maps Pinpoint Origin of Indo-European Languages
By Alyssa Joyce of Nature magazine [More]
Source: Scientific American Topic - Biotechnology - August 23, 2012 Category: Biotechnology Tags: More Science,Chemistry,Ethics,Language & Linguistics,Biotechnology,Biology,More Science Source Type: news

NISO Publishes Journal Article Tag Suite (JATS) Standard
The National Information Standards Organization (NISO) announced August 22, 2012 that it has published JATS: Journal Article Tag Suite as a new American National Standard (ANSI/NISO Z39.96-2012). JATS is a continuation of work done at the National Library of Medicine's National Center for Biotechnology Information (NCBI) to create and support the NLM Archiving and Interchange Tag Suite, commonly referred to as "the NLM DTDs." A DTD or Document Type Definition is a set of markup declarations that define a document type for a Standard Generalized Markup Language (SGML)-family markup language, such as XML and HTML.
Source: NLM General Announcements - August 23, 2012 Category: Databases & Libraries Source Type: news

Maxim Group Initiates Research Coverage of StemCells, Inc. With Buy Recommendation
NEWARK, Calif., Aug. 23, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Maxim Group LLC initiated independent research coverage on the Company with a "Buy" recommendation. The report was authored by Jason Kolbert, Senior Biotechnology Analyst at Maxim Group.
Source: Medical News (via PRIMEZONE) - August 23, 2012 Category: Pharmaceuticals Source Type: news

SmallCapVoice Announces a New Audio Interview With Dr. Simon Craw, Executive Vice President of International Stem Cell Corporation
AUSTIN, Texas, Aug. 23, 2012 (GLOBE NEWSWIRE) -- SmallCapVoice announced today that a new audio interview with International Stem Cell Corporation (ISCO) (www.internationalstemcell.com), a California-based biotechnology company focused on therapeutic and research products, is now available. The interview can be heard at http://smallcapvoice.com/blog/8-16-12-smallcapvoice-interview-with-international-stem-cell-corporation-otcbb-isco
Source: Medical News (via PRIMEZONE) - August 23, 2012 Category: Pharmaceuticals Source Type: news

Do Post-Market Drug Trials Need a Higher Dose of Ethics?
Say you have high blood pressure . There's a new blockbuster drug on the market, and your doctor lets you know about a new clinical trial you can join that is testing the new treatment against an old tried-and-true one. What's not to like? You're going to be taking, under the care of experts, one of two U.S. Food and Drug Administration–approved medications. [More]
Source: Scientific American Topic - Medical Technology - August 23, 2012 Category: Consumer Health News Tags: Health,Health,Mind & Brain,Technology,Society Policy,Everyday Science,More Science,Addiction Recovery,Pharmaceuticals,Neuroscience,Psychiatry,Psychology,Thought Cognition,Biotechnology,Biotechnology,Ethics,Infectious Diseases,Medical Technology, Source Type: news

Ranbaxy Laboratories withdraws applications of 27 drugs filed with USFDA
Ranbaxy Laboratories has agreed to withdraw applications of 27 drugs filed with the US Foods and Drug Administration.
Source: The Economic Times Healthcare and Biotech News - August 22, 2012 Category: Pharmaceuticals Source Type: news

PhaseBio begins Phase IIb type 2 diabetes trial of Glymera
PhaseBio Pharmaceuticals, a clinical-stage biotechnology company, has begun patient dosing in a multicentre Phase IIb trial to evaluate use of Glymera for the treatment of uncontrolled type 2 diabetes.
Source: Drug Development Technology - August 22, 2012 Category: Pharmaceuticals Source Type: news

Wockhardt receives tentative US FDA approval for generic version of anti-psychotic drug Geodon(R)
PARSIPPANY, N.J. and MUMBAI, India, Aug. 22, 2012 (HSMN NewsFeed) -- Pharmaceutical and biotechnology major Wockhardt has received tentative US FDA approval for marketing a generic version of 20mg, 40mg, 60mg & 80mg capsules containing Ziprasidone hydroc... Biopharmaceuticals, Generics, FDAWockhardt, Ziprasidone, Geodon, Pfizer
Source: HSMN NewsFeed - August 22, 2012 Category: Pharmaceuticals Source Type: news

WestCoast Pharma foray’s into online pharmacy store
Drugneed.com is owned by DF Pharmacy Ltd, a part of WestCoast Pharma, and was launched after a year-long pilot project.
Source: The Economic Times Healthcare and Biotech News - August 22, 2012 Category: Pharmaceuticals Source Type: news

Wockhardt gets tentative USFDA nod for anti-psychotic drug
Pharmaceutical firm Wockhardt today said it has received tentative approval from US health regulator for its generic version of anti-psychotic drug Geodon.
Source: The Economic Times Healthcare and Biotech News - August 22, 2012 Category: Pharmaceuticals Source Type: news

Supreme Court defers Novartis' patent appeal to September 11
Supreme Court on Wednesday deferred Swiss company Novartis' case against Indian government over the interpretation of Section 3 (d) of the Indian patent laws to September 11.
Source: The Economic Times Healthcare and Biotech News - August 22, 2012 Category: Pharmaceuticals Source Type: news

To Protect Against Drug Shortages, Canada Needs National Approach
Canada needs a national approach to managing its supply of pharmaceutical drugs, starting with a mandatory reporting system for drug shortages, argues an editorial in CMAJ (Canadian Medical Association Journal). and CPJ (Canadian Pharmacists Journal). Shortages of drugs, particularly those used in chemotherapy, as well as antibiotics, antiepileptics and anesthetics, have become increasingly common, unpredictable and widespread in Canada...
Source: Health News from Medical News Today - August 22, 2012 Category: Consumer Health News Tags: Pharma Industry / Biotech Industry Source Type: news

Pyng Medical Corp.: Pyng Medical Corp. Reports Third Quarter Fiscal 2012 Results
VANCOUVER, BRITISH COLUMBIA (MARKET WIRE) Pyng Medical Corp. (TSX VENTURE: PYT) today announced its financial and operating results for the three and nine months ended June 30, 2012. All amounts are in Canadian dollars unless stated otherwise.
Source: Market Wire - Pharmaceuticals and Biotech - August 21, 2012 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare PYT Source Type: news

Ingen Technologies Inc.: Ingen to Finalize SomaLife Acquisition Earlier Than Originally Expected
RIVERSIDE, CA (MARKET WIRE) Ingen Technologies, Inc. (PINKSHEETS: IGNT), an emerging medical device manufacturer with proprietary medical products for the growing $4 billion respiratory markets, announced today that the company will close the acquisition with SomaLife sooner than originally expected which should be by mid-October.
Source: Market Wire - Pharmaceuticals and Biotech - August 21, 2012 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare IGNT Source Type: news

Monoclonal Antibody Expression in Mammalian Cells
In the past two decades, the production levels for monoclonal antibodies in mammalian expression systems have improved dramatically. Single cell productivity for monoclonal antibodies has increased 20–50 fold due to the improvements in expression hosts, expression vectors, cell culture media, and production processes. However, most of these improvements are proprietary to large pharmaceutical/biotech companies and involve large steel-tank bioreactors. Therefore, these processes are difficult for small companies and academic labs to reproduce. Transient expression in mammalian cells has recently been used very widely ...
Source: Springer protocols feed by Immunology - August 21, 2012 Category: Allergy & Immunology Source Type: news

Intellectual Property Appellate Board postpones Bayer's compulsory licence appeal
IPAB has postponed German company Bayer AG's appeal against the grant of a compulsory licence of its patented drug Nexavar to Natco Pharma to September 3
Source: The Economic Times Healthcare and Biotech News - August 21, 2012 Category: Pharmaceuticals Source Type: news

1,144 people died during clinical trials in 2010, 2011
As many as 1,144 people died during clinical drug trials in 2010 and 2011, Health and Family Welfare Minister Ghulam Nabi Azad informed the Rajya Sabha today.
Source: The Economic Times Healthcare and Biotech News - August 21, 2012 Category: Pharmaceuticals Source Type: news

Wockhardt gets final USFDA approval for anti-hypertension drug
Wockhardt today said it has received final approval from the US health regulator to market generic Felodipine tablets used for treating hypertension in the US.
Source: The Economic Times Healthcare and Biotech News - August 21, 2012 Category: Pharmaceuticals Source Type: news

PolyMedix Antibiotic Studies Accepted for Presentation at ICAAC
RADNOR, Pa., Aug. 21, 2012 (GLOBE NEWSWIRE) -- PolyMedix, Inc. (OTCBB:PYMX), a biotechnology company focused on developing innovative therapeutic drugs to treat patients with serious acute-care conditions, today announced that six abstracts were accepted for presentation at the 52nd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, CA, September 9-12, 2012. In addition, PolyMedix will participate in an oral symposium. The presentations will be on PolyMedix's defensin-mimetic antimicrobial compounds in development, including results from a Phase 2 clinical study with PolyMedix...
Source: Medical News (via PRIMEZONE) - August 21, 2012 Category: Pharmaceuticals Source Type: news

Claris Lifesciences to resume export to US post USFDA nod
The approval will allow Claris to manufacture and sell its products in te US and also receive abbreviated new drug application approvals, the company said.
Source: The Economic Times Healthcare and Biotech News - August 21, 2012 Category: Pharmaceuticals Source Type: news

Nanoparticles Minimize Brain Injury from Trauma
Researchers at Rice University and Baylor College of Medicine have found that nanoparticles can reduce brain damage that occurs during treatment of even relatively mild trauma. Infusion of clusters of chemically linked carbon nanotubes called PEG-HCC rapidly and effectively neutralize free radicals produced by cells at the injury site....Read Full Post
Source: About.com Biotech Biomedical - August 21, 2012 Category: Biotechnology Source Type: news

Bilcare to sell global clinical supplies biz for Rs 340 cr
Bilcare Ltd said it will sell its global clinical supplies business in the US and UK for $ 61 million (around Rs 340 crore) to Ireland-based United Drug Plc.
Source: The Economic Times Healthcare and Biotech News - August 20, 2012 Category: Pharmaceuticals Source Type: news

Quincy Bioscience Makes Inc. 500 List of America's Fastest Growing Companies
MADISON, Wis., Aug. 20, 2012 (GLOBE NEWSWIRE) -- In the first year of eligibility, Quincy Bioscience has been included in the Inc. 500 list of fastest growing private companies in the United States, and has been ranked at #398. Quincy Bioscience, based in Madison, WI, is a biotechnology company committed to improving cognitive health in the aging population.
Source: Medical News (via PRIMEZONE) - August 20, 2012 Category: Pharmaceuticals Source Type: news

Fina Biosoultions LLC: Fina Biosolutions Licenses Rights to Its Vaccine Conjugation Technology for Development and Manufacturing of PNEUMOCOCCAL Vaccines in China to Chengdu Institute of Biological Products Co., Ltd
ROCKVILLE, MD (MARKET WIRE) Fina Biosolutions LLC, a research and development stage biotechnology company focused on developing affordable conjugate vaccines, and The Chengdu Institute of Biological Products Co., Ltd (CDIBP) announced their agreement to license Finabio's conjugate vaccine technology for the development and manufacturing of Pneumococcal conjugate vaccines in China. The agreement will accelerate the multi-valent Pneumococcal vaccine development program at CDIBP.
Source: Market Wire - Pharmaceuticals and Biotech - August 20, 2012 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare Source Type: news

TAU Research Says Genetics Can Reveal Your Geographic Ancestral Origin
While your DNA is unique, it also tells the tale of your family line. It carries the genetic history of your ancestors down through the generations. Now, says a Tel Aviv University researcher, it's also possible to use it as a map to your family's past. Prof. Eran Halperin of TAU's Blavatnik School of Computer Science and Department of Molecular Microbiology and Biotechnology, along with a group of researchers from University of California, Los Angeles, are giving new meaning to the term "genetic mapping...
Source: Health News from Medical News Today - August 20, 2012 Category: Consumer Health News Tags: Genetics Source Type: news

Thomas Kuhn: the man who changed the way the world looked at science
Fifty years ago, a book by Thomas Kuhn altered the way we look at the philosophy behind science, as well as introducing the much abused phrase 'paradigm shift'Fifty years ago this month, one of the most influential books of the 20th century was published by the University of Chicago Press. Many if not most lay people have probably never heard of its author, Thomas Kuhn, or of his book, The Structure of Scientific Revolutions, but their thinking has almost certainly been influenced by his ideas. The litmus test is whether you've ever heard or used the term "paradigm shift", which is probably the most used – and abused –...
Source: Guardian Unlimited Science - August 18, 2012 Category: Science Authors: John Naughton Tags: Science Source Type: news

Synthetic Biology Book Published in DNA
From Nature magazine [More]
Source: Scientific American Topic - Biotechnology - August 17, 2012 Category: Biotechnology Tags: Technology,Technology,Communications,Biotechnology,Biotechnology,Biology,More Science Source Type: news

Where physics meets biology
Although science is often taught as if the disciplines were clearly separated, exciting things can happen when the boundaries blurAggregates of the protein fragment (A β 1-40) associated with Alzheimer's disease, grown in a test-tube. Photograph: Danielle CannonThe Higgs boson and the probability that it's been found have been much in the news recently; so has the safe landing on Mars of Nasa's Curiosity. Good times for physicists in making mainstream newspapers, it would seem. But other physicists are quietly beavering away in less visible ways, doing what they've always done best: exploring the world around them wit...
Source: Guardian Unlimited Science - August 17, 2012 Category: Science Authors: Athene Donald Tags: Blogposts People in science Biology guardian.co.uk Physics Source Type: news

Cipla hopeful of achieving 12-15 per cent revenue growth in FY13
Pharma major Cipla Ltd today said it is hopeful of achieving 12-15 per cent revenue growth in the current financial year.
Source: The Economic Times Healthcare and Biotech News - August 17, 2012 Category: Pharmaceuticals Source Type: news

Biotech Firm Has Plans to Grow in Tucson
[the Arizona Daily Star, Tucson] From Arizona Daily Star (Tucson) (August 17, 2012) Aug. 17--A Denver company is moving to Tucson with ambitious growth plans and hopes of creating a biotech hub to...
Source: Drugs.com - Pharma News - August 17, 2012 Category: Pharmaceuticals Source Type: news

Gene patents upheld in US court
A court in the US has again backed a US biotech company's right to patent genes which have been isolated from the human body.
Source: BBC News | Health | UK Edition - August 17, 2012 Category: Consumer Health News Source Type: news

Ranbaxy Laboratories launches authorized generic Actos in US
Ranbaxy has launched authorized pioglitazone hydrochloride tablets, generic version of Takeda's diabetes drug sold under the brand Actos in US.
Source: The Economic Times Healthcare and Biotech News - August 17, 2012 Category: Pharmaceuticals Source Type: news

Strides Arcolabs unit sale attracts Novartis, Pfizer & Kohlberg Kravis Roberts
Global drug-makers including Novartis and Pfizer are among ‘serious bidders’ considering bidding for Bangalore-based Strides Arcolabs injectable-drugs unit, Agila Specialties, two people aware of the matter said.
Source: The Economic Times Healthcare and Biotech News - August 17, 2012 Category: Pharmaceuticals Source Type: news

Linking patented drugs price to per capita income may hit generic drug makers: Experts
A government panel's proposal to link the price of patented drugs to per capita income is likely to shut out the option of compulsory licensing for generic drug makers.
Source: The Economic Times Healthcare and Biotech News - August 17, 2012 Category: Pharmaceuticals Source Type: news

Why All the Concern over Genetically Modified Food?
Although genetically modified (GM) food has been on supermarket shelves for almost 15 years and consumed by hundreds of million people, there is still a lot of controversy regarding its safety. Most of this concern is drive by anti-GM group such as GM Watch and Say No to GMOs who continue to sound the alarm about the potential dangers of food from genetically engineered crops. With the ubiquity of GM food, is there still any reason to be concerned about its safety?...Read Full Post
Source: About.com Biotech Biomedical - August 17, 2012 Category: Biotechnology Source Type: news

Court Reaffirms Right of Myriad Genetics to Patent Genes
The company may patent two genes linked to breast and ovarian cancer, but may not patent methods of “comparing” or “analyzing” DNA sequences.
Source: NYT Health - August 16, 2012 Category: Consumer Health News Authors: By REUTERS Tags: Genetics and Heredity Biotechnology Inventions and Patents Decisions and Verdicts Alan Lourie University of Utah Suits and Litigation Breast Cancer Myriad Genetics Inc MYGN NASDAQ Courts and the Judiciary Ovarian Cancer Source Type: news

Ruling Lets Firm Patent Human Genes
A divided federal appeals court reaffirmed its ruling last year that isolated human genes can be patented, a victory for the biotechnology industry.
Source: WSJ.com: Health - August 16, 2012 Category: Pharmaceuticals Tags: PAID Source Type: news

Windfall likely for Ranbaxy Laboratories after FDA says no to Watson Pharmaceuticals
The US drug regulator's refusal to allow Watson Pharma to launch generic version of diabetes drug could mean windfall for Ranbaxy, according to a brokerage.
Source: The Economic Times Healthcare and Biotech News - August 16, 2012 Category: Pharmaceuticals Source Type: news

Oncolytics completes enrolment in UK Phase I cancer trial
Oncolytics Biotech, a Calgary-based biotechnology company, has completed patient enrolment in a UK Phase I clinical trial investigating Reolysin in combination with cyclophosphamide in patients with advanced malignancies. Reolysin is the company's pr…
Source: Drug Development Technology - August 16, 2012 Category: Pharmaceuticals Source Type: news

Court Rules Biotech Firm Can Patent Human Genes
A divided federal appeals court reaffirmed its ruling last year that isolated human genes can be patented, a victory for the biotechnology industry.
Source: WSJ.com: Health - August 16, 2012 Category: Pharmaceuticals Tags: PAID Source Type: news

Cancer-Fighting Compound Might Double as Reversible Male Contraceptive
From Nature Medicine 's "Spoonful of Medicine" blog : [More]
Source: Scientific American Topic - Biotechnology - August 16, 2012 Category: Biotechnology Tags: Health,Health,Society & Policy,Pharmaceuticals,More Science,Biotechnology,Biotechnology,Biology,Everyday Science Source Type: news

Court Rules for Myriad on Gene Patents
A divided federal appeals court reaffirmed its ruling last year that isolated human genes can be patented, a victory for the biotechnology industry.
Source: WSJ.com: Health - August 16, 2012 Category: Pharmaceuticals Tags: PAID Source Type: news

Nuvilex Endorses Proposed Congressional Legislation on Pancreatic Cancer Initiative
SILVER SPRING, Md., Aug. 16, 2012 (GLOBE NEWSWIRE) -- Nuvilex, Inc. (OTCQB: NVLX), an international biotechnology provider of cell and gene therapy solutions, announced today it has contacted several key members of congress, lending its support to the Pancreatic Cancer Research and Education Act (S. 362/H.R. 733).
Source: Medical News (via PRIMEZONE) - August 16, 2012 Category: Pharmaceuticals Source Type: news

Pharma industry projected to grow 18 per cent by 2016-17: Government
Indian pharmaceutical industry is poised to grow at the rate of 18 per cent by the year 2016-17, the Parliament was informed today.
Source: The Economic Times Healthcare and Biotech News - August 16, 2012 Category: Pharmaceuticals Source Type: news

Wockhardt gets nod for tablets to check heart attack
Drug firm Wockhardt said it has received USFDA approval to market clopidogrel bisulfate tablets used for reducing risk of heart attack.
Source: The Economic Times Healthcare and Biotech News - August 16, 2012 Category: Pharmaceuticals Source Type: news

Pharma council seeks changes to tax laws on export credit
Pharma Export Promotion Council has written to ministries of commerce and finance to amend tax laws with respect to export credit.
Source: The Economic Times Healthcare and Biotech News - August 16, 2012 Category: Pharmaceuticals Source Type: news

PA Department of Health presents nearly $3.1M in health research grants
Pennsylvania Department of Health Executive Deputy Secretary Michael Wolf today presented nearly $3.1 million in Commonwealth Universal Research Enhancement Program, or CURE, grants to support three, two-year research projects focused on cancer treatment technologies. The grant recipients are Apogee Biotechnology Corporation, Oncoceutics, Inc. and Penn State College of Medicine in collaboration with Keystone Nano, Inc. The CURE program funds health research with the purpose of discovering new scientific knowledge to help improve the health of all Pennsylvanians. read more
Source: Healthcare IT News Press Releases - August 15, 2012 Category: Information Technology Authors: Industry News Release Tags: Apogee Biotechnology Corporation cancer treatment Department of Health Dept of Health Industry News Keystone Nano Inc. Michael Wolf Oncoceutics Inc. Penn State College of Medicine Pennsylvania Source Type: news

Whistleblower Lawsuit Alleges Genentech Rushed Clinical Trials
Biotech giant Genentech put participants in its human trials for a cancer drug at risk by not following clinical rules and fired a high-level employee who questioned why the company was racing toward the approval deadline, according to a lawsuit filed by the worker who said she was targeted for whistle-blowing.
Source: PharmaManufacturing.com - August 15, 2012 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: news